Search Results 1461-1470 of 14744 for anti-TNF drugs

  1. Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits (PGNMID) - Mayo Clinic

    The purpose of this study is to assess the effectiveness of daratumumab SC in treating patients with monoclonal immunoglobulin deposits (PGNMID) by assessing ...

  2. Testosterone (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  3. Norgestrel (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  4. Tafenoquine (Oral Route) Description and Brand Names - Mayo Clinic

    Tafenoquine belongs to a group of medicines, called antiprotozoals. It works by treating malaria, a red blood cell infection transmitted by the bite of a ...

  5. Prophylactic Benzodiazepine versus Reinstitution of Maintenance Antiseizure Drugs following Ictal SPECT - Mayo Clinic

    Prophylactic Benzodiazepine versus Reinstitution of Maintenance Antiseizure Drugs following Ictal SPECT · Overview · Participation eligibility · Participating Mayo ...

  6. Belantamab Mafodotin-Blmf (Intravenous Route) Description and Brand Names - Mayo Clinic

    Drugs and Supplements · Belantamab Mafodotin-Blmf ... anti-CD38 monoclonal antibody, a proteasome ... Drugs & Supplements; Belantamab Mafodotin-Blmf ...

  7. Tobramycin And Dexamethasone (Ophthalmic Route) Before Using - Mayo Clinic

    Allergies. Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care ...

  8. Teriflunomide (Oral Route) Proper Use - Mayo Clinic

    Teriflunomide may stay in your blood for up to 2 years after your treatment. Your doctor may want you to use activated charcoal or cholestyramine (Questran®) to ...

  9. Dimethyl Sulfoxide (Intravesical Route) Description and Brand Names - Mayo Clinic

    Interstitial cystitis is the only human use for dimethyl sulfoxide that is approved by the U.S. Food and Drug Administration (FDA).

  10. Ado-Trastuzumab Emtansine (Intravenous Route) Description and Brand Names - Mayo Clinic

    It is also used as additional treatment in patients with HER2-positive early breast cancer who have cancer left after a taxane medicine and trastuzumab-based ...